Cannell Capital - CYTEIR THERAPEUTICS INC ownership

CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 33 filers reported holding CYTEIR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Cannell Capital ownership history of CYTEIR THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$35,825
+10.3%
19,6840.0%0.01%0.0%
Q4 2022$32,479
-14.5%
19,6840.0%0.01%
-22.2%
Q3 2022$38,000
+216.7%
19,684
+405.9%
0.01%
+350.0%
Q2 2022$12,0003,8910.00%
Other shareholders
CYTEIR THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Novo Holdings A/S 4,840,413$84,949,0004.39%
ACUTA CAPITAL PARTNERS, LLC 391,974$6,879,0002.43%
Ally Bridge Group (NY) LLC 319,538$5,608,0001.65%
RA Capital Management 3,350,506$58,801,0000.82%
Avidity Partners Management LP 1,683,441$29,544,0000.66%
Sofinnova Investments, Inc. 246,321$4,323,0000.26%
CAAS CAPITAL MANAGEMENT LP 579,746$10,175,0000.20%
SPHERA FUNDS MANAGEMENT LTD. 135,145$2,372,0000.20%
ACT CAPITAL MANAGEMENT, LLC 15,000$263,0000.14%
Baker Brothers Advisors 812,640$14,262,0000.06%
View complete list of CYTEIR THERAPEUTICS INC shareholders